chr2-102478945-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001011552.4(SLC9A4):c.363G>A(p.Ser121Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.45 in 1,613,808 control chromosomes in the GnomAD database, including 168,329 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).
Frequency
Genomes: 𝑓 0.42 ( 14130 hom., cov: 33)
Exomes 𝑓: 0.45 ( 154199 hom. )
Consequence
SLC9A4
NM_001011552.4 synonymous
NM_001011552.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.426
Genes affected
SLC9A4 (HGNC:11077): (solute carrier family 9 member A4) Predicted to enable potassium:proton antiporter activity and sodium:proton antiporter activity. Predicted to be involved in potassium ion transmembrane transport; regulation of intracellular pH; and sodium ion import across plasma membrane. Predicted to act upstream of or within epithelial cell development and gastric acid secretion. Predicted to be located in several cellular components, including apical plasma membrane; basolateral plasma membrane; and vacuolar membrane. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.481 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.416 AC: 63229AN: 151910Hom.: 14122 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
63229
AN:
151910
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.418 AC: 104990AN: 251356 AF XY: 0.425 show subpopulations
GnomAD2 exomes
AF:
AC:
104990
AN:
251356
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.454 AC: 662918AN: 1461778Hom.: 154199 Cov.: 78 AF XY: 0.453 AC XY: 329395AN XY: 727202 show subpopulations
GnomAD4 exome
AF:
AC:
662918
AN:
1461778
Hom.:
Cov.:
78
AF XY:
AC XY:
329395
AN XY:
727202
Gnomad4 AFR exome
AF:
AC:
9862
AN:
33480
Gnomad4 AMR exome
AF:
AC:
13409
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
11931
AN:
26136
Gnomad4 EAS exome
AF:
AC:
8249
AN:
39682
Gnomad4 SAS exome
AF:
AC:
30351
AN:
86256
Gnomad4 FIN exome
AF:
AC:
31853
AN:
53340
Gnomad4 NFE exome
AF:
AC:
527880
AN:
1111996
Gnomad4 Remaining exome
AF:
AC:
26643
AN:
60396
Heterozygous variant carriers
0
24690
49380
74071
98761
123451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
15324
30648
45972
61296
76620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.416 AC: 63256AN: 152030Hom.: 14130 Cov.: 33 AF XY: 0.420 AC XY: 31238AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
63256
AN:
152030
Hom.:
Cov.:
33
AF XY:
AC XY:
31238
AN XY:
74300
Gnomad4 AFR
AF:
AC:
0.293443
AN:
0.293443
Gnomad4 AMR
AF:
AC:
0.367279
AN:
0.367279
Gnomad4 ASJ
AF:
AC:
0.464553
AN:
0.464553
Gnomad4 EAS
AF:
AC:
0.226796
AN:
0.226796
Gnomad4 SAS
AF:
AC:
0.355247
AN:
0.355247
Gnomad4 FIN
AF:
AC:
0.612247
AN:
0.612247
Gnomad4 NFE
AF:
AC:
0.485185
AN:
0.485185
Gnomad4 OTH
AF:
AC:
0.446547
AN:
0.446547
Heterozygous variant carriers
0
1822
3644
5466
7288
9110
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
592
1184
1776
2368
2960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1140
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Ascending aortic dissection Other:1
Feb 01, 2021
Beijing Anzhen Hospital, Capital Medical University
Significance:association
Review Status:no assertion criteria provided
Collection Method:case-control
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=98/2
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at